Core Viewpoint - The announcement details the signing of a strategic cooperation agreement between Tianchen Medical and Inspur Digital Technology (Shanghai) Co., Ltd, aimed at promoting innovation and industrialization in medical intelligence and information technology [2][3]. Group 1: Agreement Overview - The strategic cooperation agreement is a framework agreement that does not specify any financial commitments, with specific cooperation details to be defined in future contracts [2][3]. - The agreement was signed on December 31, 2025, in Shanghai, and does not require board or shareholder approval as it is an intention-based agreement [4][12]. - The agreement establishes a partnership to leverage both companies' resources to advance medical intelligence and information technology in medical device manufacturing and medical robotics [3][12]. Group 2: Cooperation Details - The cooperation will focus on several areas, including: - Medical intelligence and information technology, where Inspur will provide digital solutions for Tianchen's smart factory design and supply chain management [5][12]. - Joint research and development in medical robotics, combining Inspur's technology with Tianchen's expertise in medical devices [5][12]. - Market collaboration and brand building, where both companies will prioritize each other's products and services and participate in joint promotional activities [6][7]. Group 3: Impact on Company - The signing of the agreement is a significant step in implementing the company's dual-engine strategy, which focuses on minimally invasive capabilities and intelligent surgical robotics [12]. - The agreement is expected to provide a framework for future project cooperation, facilitating industrial integration and mutual benefits without affecting the company's main business or independence [12].
天臣国际医疗科技股份有限公司关于自愿披露签订战略合作协议的公告